Partners
Courtney E. Heron, BS, Rima I. Ghamrawi, BS, Steven R. Feldman, MD, PhD
The evolving pathogenesis and various phenotypic presentations of atopic dermatitis (AD) can guide research to important discoveries in immunotherapy and future therapies, highlighting a positive future in the treatment of AD.
Lauren Mateja, Managing Editor
The Dermatologist spoke with investigators behind two prominent international registries dedicated to better understanding how concomitant psoriasis and COVID-19 can affect patient care and outcomes now and in the future.
Lauren Mateja, Managing Editor
A National Rosacea Society expert roundtable discussed the need to address persistent facial erythema in patients with rosacea through research and management options.
Sonya Zarkhin, DO, Nichelle Madden, DO, Kristi Hawley, DO, Sean Stephenson, DO
Linear psoriasis, a rare variant of psoriasis, is not well understood, but its course of treatment is similar to other psoriatic presentations. The authors report a successfully treated case of linear psoriasis in a 19-year-old female patient.
Jessica E. Payne, BS, Rima I. Ghamrawi, BS, Lindsay C. Strowd, MD
Atopic dermatitis can have a significant effect on the quality of life of all patients, especially for the children and adolescents who are primarily affected by the disease.
Lauren Mateja, Managing Editor
The Centers for Disease Control and Prevention and World Health Organization advise that hand washing is critical to slowing the spread of infection, but patients with dermatitis may need further guidance from their dermatologists.
Lauren Mateja, Managing Editor
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass on to their patients.
Lauren Mateja, Managing Editor
The number of therapeutic options for rosacea management has expanded, but these treatments can only help patients who have been diagnosed. Rosacea Awareness Month seeks to help identify patients who may otherwise ignore their warning signs.
Lauren Mateja, Managing Editor
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
Lauren Mateja, Managing Editor
A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.